Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety: Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06181045
What this trial is testing

LY3410738 in Healthy Adult Participants

Who this might be right for
Healthy
Eli Lilly and Company 42
Early research (Phase 1)Not Yet RecruitingNCT07833072
What this trial is testing

This Phase 1a Study Will Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Relative Bioavailability of Single-dose DMI019 Nasal Spray in Healthy Participants.

Who this might be right for
Healthy Volunteers
The Third Xiangya Hospital of Central South University 48
Early research (Phase 1)Study completedNCT00550381
What this trial is testing

Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects

Who this might be right for
Healthy
Wyeth is now a wholly owned subsidiary of Pfizer 72
Early research (Phase 1)Study completedNCT06423872
What this trial is testing

A SAD Study of ZT002 Injection in Healthy Participants

Who this might be right for
Type 2 Diabetes Mellitus
Beijing QL Biopharmaceutical Co.,Ltd 28
Early research (Phase 1)Study completedNCT06069895
What this trial is testing

Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants

Who this might be right for
Healthy Participants
Novo Nordisk A/S 170
Large-scale testing (Phase 3)Study completedNCT02839330
What this trial is testing

Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Who this might be right for
Avian Influenza
Seqirus 3,196
Early research (Phase 1)Study completedNCT02801981
What this trial is testing

Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers

Who this might be right for
Cholestasis
GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT00408109
What this trial is testing

Safety Study of Avian Flu Vaccine

Who this might be right for
Influenza A Virus, H5N1 SubtypeInfluenza A VirusInfluenzavirus A+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 45
Early research (Phase 1)Study completedNCT01687309
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 19
Early research (Phase 1)Study completedNCT06298032
What this trial is testing

A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Persons

Who this might be right for
Inflammatory Gastrointestinal Diseases
Ferring Pharmaceuticals 49
Early research (Phase 1)Study completedNCT01741519
What this trial is testing

Long-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers

Who this might be right for
Healthy
AOP Orphan Pharmaceuticals AG 14
Early research (Phase 1)Study completedNCT03918967
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants

Who this might be right for
Healthy
Celltrion 72
Early research (Phase 1)Study completedNCT01606371
What this trial is testing

A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 32
Early research (Phase 1)Study completedNCT03430232
What this trial is testing

First-In-Human PainCart Study for STR-324

Who this might be right for
Pain
Stragen France 78
Early research (Phase 1)Study completedNCT06286475
What this trial is testing

VRG50635 in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Verge Genomics 22
Early research (Phase 1)Study completedNCT01568281
What this trial is testing

Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects

Who this might be right for
SafetyPharmacokinetics
AstraZeneca 58
Early research (Phase 1)Study completedNCT01709019
What this trial is testing

RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly

Who this might be right for
Respiratory Syncytial Virus (RSV)
Novavax 220
Early research (Phase 1)Study completedNCT03662971
What this trial is testing

Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers

Who this might be right for
Corneal Defect
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 42
Early research (Phase 1)Study completedNCT05127564
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Diroximel Fumarate (DRF) in Chinese and Caucasian Adult Healthy Participants

Who this might be right for
Healthy Volunteers
Biogen 32
Early research (Phase 1)Study completedNCT01862939
What this trial is testing

A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Daiichi Sankyo 52
Next Page